SenNet recommendations for detecting senescent cells in different tissues
- PMID: 38831121
- PMCID: PMC11578798
- DOI: 10.1038/s41580-024-00738-8
SenNet recommendations for detecting senescent cells in different tissues
Abstract
Once considered a tissue culture-specific phenomenon, cellular senescence has now been linked to various biological processes with both beneficial and detrimental roles in humans, rodents and other species. Much of our understanding of senescent cell biology still originates from tissue culture studies, where each cell in the culture is driven to an irreversible cell cycle arrest. By contrast, in tissues, these cells are relatively rare and difficult to characterize, and it is now established that fully differentiated, postmitotic cells can also acquire a senescence phenotype. The SenNet Biomarkers Working Group was formed to provide recommendations for the use of cellular senescence markers to identify and characterize senescent cells in tissues. Here, we provide recommendations for detecting senescent cells in different tissues based on a comprehensive analysis of existing literature reporting senescence markers in 14 tissues in mice and humans. We discuss some of the recent advances in detecting and characterizing cellular senescence, including molecular senescence signatures and morphological features, and the use of circulating markers. We aim for this work to be a valuable resource for both seasoned investigators in senescence-related studies and newcomers to the field.
© 2024. Springer Nature Limited.
Conflict of interest statement
Competing interests: The authors declare the following competing interests: J.C. is a founder and shareholder of Unity Biotechnology, which develops senolytic drugs. M.J.S., C.M.C. and Mayo Clinic have intellectual property related to this research. Research in the M.J.S. and D.J.B. laboratory is reviewed by the Mayo Clinic Conflict of Interest Review Board and conducted in compliance with Mayo Clinic Conflict of Interest policies. D.J.B. has a potential financial interest related to this research; he is a co-inventor on patents held by Mayo Clinic and patent applications licensed to or filed by Unity Biotechnology and a Unity Biotechnology shareholder. N. Slavov is a founding director and CEO of Parallel Squared Technology Institute, which is a non-profit research institute.
References
Publication types
MeSH terms
Substances
Grants and funding
- R01 DK132535/DK/NIDDK NIH HHS/United States
- UG3 CA275686/CA/NCI NIH HHS/United States
- U54 AG075934/AG/NIA NIH HHS/United States
- U54 AG079753/AG/NIA NIH HHS/United States
- R01 AG069819/AG/NIA NIH HHS/United States
- T32 GM136566/GM/NIGMS NIH HHS/United States
- U54 AG079758/AG/NIA NIH HHS/United States
- R33 AG061456/AG/NIA NIH HHS/United States
- U54 AG075941/AG/NIA NIH HHS/United States
- U54 AG076041/AG/NIA NIH HHS/United States
- F31 AG072748/AG/NIA NIH HHS/United States
- U54 AG079759/AG/NIA NIH HHS/United States
- U54 AG076040/AG/NIA NIH HHS/United States
- R01 AG076642/AG/NIA NIH HHS/United States
- R01 DK127778/DK/NIDDK NIH HHS/United States
- UG3 CA268096/CA/NCI NIH HHS/United States
- P30 ES001247/ES/NIEHS NIH HHS/United States
- R01 AG076515/AG/NIA NIH HHS/United States
- RM1 HG011014/HG/NHGRI NIH HHS/United States
- U54 AG079754/AG/NIA NIH HHS/United States
- P30 DK036836/DK/NIDDK NIH HHS/United States
- UG3 CA268117/CA/NCI NIH HHS/United States
- UG3 CA268105/CA/NCI NIH HHS/United States
- UG3 CA268112/CA/NCI NIH HHS/United States
- UH3 CA268103/CA/NCI NIH HHS/United States
- P01 AG062413/AG/NIA NIH HHS/United States
- T32 AG041688/AG/NIA NIH HHS/United States
- UG3 CA275669/CA/NCI NIH HHS/United States
- U54 AG075932/AG/NIA NIH HHS/United States
- UH3 CA275686/CA/NCI NIH HHS/United States
- T32 MH126036/MH/NIMH NIH HHS/United States
- U54 AG079779/AG/NIA NIH HHS/United States
- U01 AG060906/AG/NIA NIH HHS/United States
- U54 AG075931/AG/NIA NIH HHS/United States
- P30 AG044271/AG/NIA NIH HHS/United States
- P01 AG017242/AG/NIA NIH HHS/United States
- UG3 CA268202/CA/NCI NIH HHS/United States
- R01 HL147290/HL/NHLBI NIH HHS/United States
- U24 CA268108/CA/NCI NIH HHS/United States
- U19 AI089992/AI/NIAID NIH HHS/United States
- R01 AG082708/AG/NIA NIH HHS/United States
- R01 AG068182/AG/NIA NIH HHS/United States
- R01 AG068048/AG/NIA NIH HHS/United States
- R01 HL147575/HL/NHLBI NIH HHS/United States
- P30 AG067988/AG/NIA NIH HHS/United States
- R01 AG050582/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources